Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS (Narrative) (Details)

v3.23.1
FINANCIAL INSTRUMENTS (Narrative) (Details)
$ / shares in Units, $ / shares in Units, € in Thousands, ₪ in Thousands, $ in Thousands, $ in Thousands
 12 Months Ended
May 10, 2021
CAD ($)
Shares
shares
May 10, 2021
USD ($)
Shares
$ / shares
Dec. 31, 2022
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2021
CAD ($)
Shares
$ / shares
shares
Dec. 31, 2020
CAD ($)
Dec. 31, 2022
EUR (€)
Shares
shares
Dec. 31, 2022
ILS (₪)
Shares
shares
Dec. 31, 2022
USD ($)
Shares
shares
Feb. 24, 2022
CAD ($)
Feb. 24, 2022
USD ($)
May 10, 2021
$ / shares
Disclosure of detailed information about financial instruments [line items]                      
Net proceeds from private placement     $ 3,756 $ 28,131 $ 0            
Issuance expenses including FV of compensation units     178 3,800              
Finance costs     $ 1,972 $ 673 [1] 20,504            
Exercise price of compensation option | $ / shares     $ 16 $ 24.3              
Number of share options granted in share-based payment arrangement | Shares     32,503 296,427              
Weighted average exercise price of share options granted in share-based payment arrangement | $ / shares     $ 10.85 $ 62              
Aggregate consideration to acquire preferred shares     $ 0 $ 13 $ 1,347            
Investments in affiliates     2,410 $ 2,429              
Investments in unlisted shares measured at fair value     $ 2,410                
Number of shares issued | shares     7,569,526 6,811,620   7,569,526 7,569,526 7,569,526      
Issuance of new warrants       $ 11,832              
Fair value of the investments     $ 2,410 2,429              
Cash transferred                 $ 125 $ 100  
2019 Warrants [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Fair value of warrants     0 15,929              
Amount of warrant transferred in equity during the period       (611)              
2021 Warrant [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Term of warrants from date of issuance 5 years 5 years                  
Fair value of warrants     $ 8 $ 6,022              
Issuance expenses including FV of compensation units $ 3,800                    
Number of warrants outstanding | Shares     304,348 304,348   304,348 304,348 304,348      
(Gain) loss on revaluation     $ 6,014 $ 5,810              
Number of warrants issued for common shares | Shares 304,348 304,348                  
Number of common shares called by warrants | shares 304,348                    
Exercise price of warrants issued per common share | $ / shares   $ 7.2                  
Issuance of new warrants $ 30,670                    
Warrant liability 11,832                    
2021 Warrant [Member] | Listed Warrants [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Issuance expenses including FV of compensation units 1,296                    
2021 Warrant [Member] | Share Capital [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Issuance expenses including FV of compensation units 2,539                    
Overnight Marketed Offering [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Net proceeds from private placement $ 42,502 $ 35,000                  
Number of share options granted in share-based payment arrangement | Shares 91,304 91,304                  
Number of shares issued | shares 608,696                    
Par value per share | $ / shares                     $ 57.5
Number of warrants issued for common shares | Shares 45,652 45,652                  
Share-based compensation $ 800                    
Currency risk [Member] | Cash And Cash Equivalent [Member] | EUR [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Risk exposure associated with instruments sharing characteristic     44     € 30          
Currency risk [Member] | Cash And Cash Equivalent [Member] | NIS [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Risk exposure associated with instruments sharing characteristic     2,328       ₪ 6,045        
Currency risk [Member] | Cash And Cash Equivalent [Member] | USD [Member]                      
Disclosure of detailed information about financial instruments [line items]                      
Risk exposure associated with instruments sharing characteristic     $ 39         $ 29      
[1] Reclassified in respect of discontinued operations - see Note 24.